Anxiety Disorders Completed Phase 2 Trials for Lorazepam (DB00186)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00807937Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325Treatment